These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 38649936

  • 21. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 22. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y, Zhu L, Zhou T, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2015 May; 10(3):e0119033. PubMed ID: 25816025
    [Abstract] [Full Text] [Related]

  • 23. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.
    Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
    [Abstract] [Full Text] [Related]

  • 24. High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.
    Wen L, Zhao Z, Wang Z, Xiao J, Birn H, Gregersen JW.
    Nephrology (Carlton); 2019 Jul; 24(7):703-710. PubMed ID: 30141239
    [Abstract] [Full Text] [Related]

  • 25. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
    Chanrat E, Worawichawong S, Radinahamed P, Sathirapongsasuti N, Nongnuch A, Assanatham M, Udomsubpayakul U, Kitiyakara C.
    Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
    [Abstract] [Full Text] [Related]

  • 26. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 27. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov 30; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 28. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S, Yang X, Luo J, Guo H.
    Int Immunopharmacol; 2020 Nov 30; 88():106896. PubMed ID: 33182045
    [Abstract] [Full Text] [Related]

  • 29. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
    Feng Y, Lv LL, Wu WJ, Li ZL, Chen J, Ni HF, Zhou LT, Tang TT, Wang FM, Wang B, Chen PS, Crowley SD, Liu BC.
    Am J Pathol; 2018 Nov 30; 188(11):2542-2552. PubMed ID: 30142333
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
    Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw, Guo Y, Sun W, Yue H.
    BMC Nephrol; 2018 Dec 14; 19(1):358. PubMed ID: 30547763
    [Abstract] [Full Text] [Related]

  • 31. Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis.
    Worawichawong S, Worawichawong S, Radinahamed P, Muntham D, Sathirapongsasuti N, Nongnuch A, Assanatham M, Kitiyakara C.
    Kidney Blood Press Res; 2016 Dec 14; 41(6):997-1007. PubMed ID: 27988512
    [Abstract] [Full Text] [Related]

  • 32. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy.
    Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH.
    BMC Nephrol; 2013 Jul 09; 14():139. PubMed ID: 23837450
    [Abstract] [Full Text] [Related]

  • 33. Significance of urinary full-length megalin in patients with IgA nephropathy.
    Seki T, Asanuma K, Asao R, Nonaka K, Sasaki Y, Oliva Trejo JA, Kurosawa H, Hirayama Y, Horikoshi S, Tomino Y, Saito A.
    PLoS One; 2014 Jul 09; 9(12):e114400. PubMed ID: 25502002
    [Abstract] [Full Text] [Related]

  • 34. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 35. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
    Stangou M, Papagianni A, Bantis C, Moisiadis D, Kasimatis S, Spartalis M, Pantzaki A, Efstratiadis G, Memmos D.
    Clin Nephrol; 2013 Sep 15; 80(3):203-10. PubMed ID: 23611517
    [Abstract] [Full Text] [Related]

  • 36. Correlation analysis of cofilin-1 with renal prognosis in primary IgA nephropathy.
    Zhao RB, Xu YS, Li XH, Wei MJ, Deng Y, Peng X, Pan L.
    BMC Nephrol; 2024 Sep 03; 25(1):289. PubMed ID: 39227817
    [Abstract] [Full Text] [Related]

  • 37. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.
    Nephrol Dial Transplant; 2015 Jul 03; 30(7):1140-50. PubMed ID: 25956757
    [Abstract] [Full Text] [Related]

  • 38. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H.
    Int Immunopharmacol; 2019 Jan 03; 66():13-18. PubMed ID: 30415190
    [Abstract] [Full Text] [Related]

  • 39. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
    Onda K, Ohsawa I, Ohi H, Tamano M, Mano S, Wakabayashi M, Toki A, Horikoshi S, Fujita T, Tomino Y.
    BMC Nephrol; 2011 Nov 23; 12():64. PubMed ID: 22111871
    [Abstract] [Full Text] [Related]

  • 40. The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study.
    Wang Z, Jiang Y, Chen P, Wang J, Zhang X, Huang B, Zhou X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2119-2127. PubMed ID: 35104893
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.